Patents by Inventor Gan Wang

Gan Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230082738
    Abstract: The present disclosure discloses an earphone. The earphone may include a hook-shaped component, a connecting component, and a holding component. When the earphone is in a wearing state, the hook-shaped component may be configured to hang between a rear side of an ear of a user and a head of the user. The holding component may be configured to contact a front side of the ear. The connecting component may be configured to connect the hook-shaped component and the holding component and extend from the head to an outside of the head to cooperate with the hook-shaped component to provide the holding component with a pressing force on the front side of the ear.
    Type: Application
    Filed: November 20, 2022
    Publication date: March 16, 2023
    Applicant: SHENZHEN SHOKZ CO., LTD.
    Inventors: Zeying ZHENG, Jiang XU, Yonggen WANG, Haofeng ZHANG, Gan LAI, Chong WANG, Liwei WANG, Ruixin HAN, Lei ZHANG, Junjiang FU
  • Publication number: 20220284191
    Abstract: Embodiments of the described technologies are capable of reading a text sequence that include at least one word; extracting model input data from the text sequence, where the model input data includes, for each word of the text sequence, segment data and non-segment data; using a first machine learning model and at least one second machine learning model, generating, for each word of the text sequence, a multi-level feature set; outputting, by a third machine learning model, in response to input to the third machine learning model of the multi-level feature set, a tagged version of the text sequence; executing a search based at least in part on the tagged version of the text sequence.
    Type: Application
    Filed: March 5, 2021
    Publication date: September 8, 2022
    Inventors: Yuwei QIU, Gonzalo ANIANO PORCILE, Yu GAN, Qin Iris WANG, Haichao WEI, Huiji GAO
  • Patent number: 10848960
    Abstract: Disclosed are a method and system for interaction between an AP and a Modem. The method comprises: when an AP end sends a message to a Modem end, acquiring a service type corresponding to the message; searching, according to the service type, in pre-set multiple RILD threads for an RILD thread corresponding thereto; and sending the message to the Modem end through the RILD thread.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: November 24, 2020
    Assignee: JRD Communication (Shenzhen) LTD.
    Inventors: Gan Wang, Ruihua Zhang, Shifeng Cao
  • Publication number: 20200145812
    Abstract: Disclosed are a method and system for interaction between an AP and a Modem. The method comprises: when an AP end sends a message to a Modem end, acquiring a service type corresponding to the message; searching, according to the service type, in pre-set multiple RILD threads for an RILD thread corresponding thereto; and sending the message to the Modem end through the RILD thread.
    Type: Application
    Filed: June 5, 2018
    Publication date: May 7, 2020
    Applicant: JRD Communication (Shenzhen) LTD.
    Inventors: Gan WANG, Ruihua ZHANG, Shifeng CAO
  • Patent number: 10617675
    Abstract: The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: April 14, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: David B. Frennesson, Piyasena Hewawasam, Omar D. Lopez, Van N. Nguyen, Mark G. Saulnier, Yong Tu, Alan Xiangdong Wang, Gan Wang, Ningning Xu, Roshan Yadavrao Nimje, Hasibur Rahaman, Samayamunthula Venkata Satya Arun Kumar Gupta, Nicholas A. Meanwell, Makonen Belema
  • Patent number: 10221129
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: March 5, 2019
    Assignee: VIIV HEALTHCARE UK (NO.5) LIMITED
    Inventors: John A. Bender, Robert G. Gentles, Annapurna Pendri, Alan Xiangdong Wang, Nicholas A. Meanwell, Brett R. Beno, Robert A. Fridell, Makonen Belema, Van N. Nguyen, Zhong Yang, Gan Wang, Selvakumar Kumaravel, Srinivasan Thangathirupathy, Rajesh Onkardas Bora, Shilpa Maheshwarappa Holehatti, Mallikarjuna Rao Mettu, Manoranjan Panda
  • Publication number: 20180221342
    Abstract: The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 9, 2018
    Inventors: David B. Frennesson, Piyasena Hewawasam, Omar D. Lopez, Van N. Nguyen, Mark G. Saulnier, Yong Tu, Alan Xiangdong Wang, Gan Wang, Ningning Xu, Roshan Yadavrao Nimje, Hasibur Rahaman, Samayamunthula Venkata Satya Arun Kumar Gupta, Nicholas A. Meanwell, Makonen Belema
  • Publication number: 20180108654
    Abstract: A method of forming a FinFET device includes ion implanting a diffusion-inhibiting species such as carbon into source and drain regions of a semiconductor fin prior to a dopant activating anneal. The implanted carbon, which can be incorporated into the fin in conjunction with a replacement metal gate process after defining a sacrificial gate but prior to forming sidewall spacers on the gate, forms a barrier that impedes dopant diffusion across the barrier, which enables abrupt junctions and higher overall dopant concentrations within the semiconductor fin.
    Type: Application
    Filed: October 14, 2016
    Publication date: April 19, 2018
    Applicant: GLOBALFOUNDRIES, INC.
    Inventors: Viorel C. ONTALUS, Arvind KUMAR, Xin WANG, Gan WANG
  • Publication number: 20180086697
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: April 22, 2016
    Publication date: March 29, 2018
    Inventors: John A. BENDER, Robert G. GENTLES, Annapurna PENDRI, Alan Xiangdong WANG, Nicholas A. MEANWELL, Brett R. BENO, Robert A. FRIDELL, Makonen BELEMA, Van N. NGUYEN, Zhong YANG, Gan WANG, Selvakumar KUMARAVEL, Srinivasan THANGATHIRUPATHY, Rajesh Onkardas BORA, Shilpa Maheshwarappa HOLEHATTI, Mallikarjuna Rao METTU, Manoranjan PANDA
  • Publication number: 20180072997
    Abstract: Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
    Type: Application
    Filed: April 22, 2016
    Publication date: March 15, 2018
    Inventors: John A. BENDER, Omar D. LOPEZ, Van N. NGUYEN, Zhong YANG, Alan Xiangdong WANG, Gan WANG, Nicholas A. MEANWELL, Brett R. BENO, Robert A. FRIDELL, Makonen BELEMA, Srinivasan THANGATHIRUPATHY
  • Publication number: 20170355689
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: August 29, 2017
    Publication date: December 14, 2017
    Inventors: RICO LAVOIE, John A. Bender, Zhong Yang, Makonen Belema, Omar D. Lopez, Qi Chen, Gan Wang, Piyasena Hewawasam
  • Patent number: 9776981
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: October 3, 2017
    Assignee: Bristol-Myers Squibb Company
    Inventors: Rico Lavoie, John A. Bender, Zhong Yang, Makonen Belema, Omar D. Lopez, Qi Chen, Gan Wang, Piyasena Hewawasam
  • Patent number: 9758487
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: September 12, 2017
    Assignee: Bristol-Myers Squibb Company
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Gan Wang, Lawrence G. Hamann
  • Patent number: 9561212
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: February 7, 2017
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jeffrey Lee Romine, Zhong Yang, Gan Wang, Van N. Nguyen, John A. Bender, Denis R. St. Laurent, Makonen Belema
  • Patent number: 9546160
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: January 17, 2017
    Assignee: Bristol-Myers Squibb Company
    Inventors: Qi Chen, Omar D. Lopez, John A. Bender, Gan Wang, Van N. Nguyen, John F. Kadow, Nicholas A. Meanwell, Makonen Belema
  • Publication number: 20160338999
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: August 3, 2016
    Publication date: November 24, 2016
    Inventors: Jeffrey Lee Romine, Zhong Yang, Gan Wang, Van N. Nguyen, John A. Bender, Denis R. St. Laurent, Makonen Belema
  • Publication number: 20160311778
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: June 28, 2016
    Publication date: October 27, 2016
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Gan Wang, Lawrence G. Hamann
  • Patent number: 9337289
    Abstract: In a replacement gate scheme, a continuous material layer is deposited on a bottom surface and a sidewall surface in a gate cavity. A vertical portion of the continuous material layer is removed to form a gate component of which a vertical portion does not extend to a top of the gate cavity. The gate component can be employed as a gate dielectric or a work function metal portion to form a gate structure that enhances performance of a replacement gate field effect transistor.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: May 10, 2016
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Zhengwen Li, Dechao Guo, Randolph F. Knarr, Chengwen Pei, Gan Wang, Yanfeng Wang, Keith Kwong Hon Wong, Jian Yu, Jun Yuan
  • Patent number: 9312358
    Abstract: A method of manufacturing a semiconductor device is disclosed. A p-type substrate is doped to form an N-well in a selected portion of a p-type substrate adjacent an anode region of the substrate. A p-type doped region is formed in the anode region of the p-type substrate. The p-type doped region and the N-well form a p-n junction.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: April 12, 2016
    Assignee: International Business Machines Corporation
    Inventors: Dechao Guo, Wilfried E. Haensch, Gan Wang, Yanfeng Wang, Xin Wang
  • Patent number: 9252234
    Abstract: A method of manufacturing a semiconductor device is disclosed. A p-type substrate is doped to form an N-well in a selected portion of a p-type substrate adjacent an anode region of the substrate. A p-type doped region is formed in the anode region of the p-type substrate. The p-type doped region and the N-well form a p-n junction.
    Type: Grant
    Filed: September 6, 2012
    Date of Patent: February 2, 2016
    Assignee: International Business Machines Corporation
    Inventors: Dechao Guo, Wilfried E. Haensch, Gan Wang, Yanfeng Wang, Xin Wang